Pharmacology, Toxicology and Pharmaceutical Science
Chronic Obstructive Lung Disease
100%
Asthma
28%
Placebo
24%
Bronchodilating Agent
21%
Formoterol
16%
Beclometasone Dipropionate
10%
Glycopyrronium
9%
Phosphodiesterase IV Inhibitor
9%
Beclometasone
9%
Inflammation
9%
Formoterol Fumarate
8%
Biological Marker
8%
Disease
7%
Dexamethasone
7%
Symptom
7%
Cytokine
7%
Muscarinic Receptor Blocking Agent
6%
Dry Powder Inhaler
6%
Pharmacokinetics
5%
Glucocorticoid
5%
Normal Human
5%
Monotherapy
5%
Immunology and Microbiology
Asthma
30%
Sputum
30%
Alveolar Macrophage
23%
Macrophage
20%
Eosinophil Count
10%
Glucocorticoid
8%
Eosinophil Granulocyte
8%
Normal Human
8%
Tumor Necrosis Factor
8%
Cytokine
8%
Antiinflammatory Activity
7%
Gene Expression
7%
Lymphocyte
7%
Phosphodiesterase-4 Inhibitor
7%
Neutrophil Granulocyte
6%
Eosinophil
6%
Dexamethasone
6%
Allergen
5%
Severe Asthma
5%
Neutrophil
5%
Cytokine Production
5%
Breathing
5%
Circadian Rhythm
5%
Microbiome
5%
Medicine and Dentistry
Chronic Obstructive Pulmonary Disease
61%
Asthma
13%
Sputum
11%
Biological Marker
9%
Eosinophil
7%
Placebo
6%
Smoking
6%
Symptom
6%
Diseases
5%
Bronchodilating Agent
5%
Breathing
5%
Neutrophil
5%
Forced Expiratory Volume
5%
